Breakthrough Treatment for Asthma, Organ Transplant and Fibrosis

Company Overview

LignaMed's experienced team of scientists and life science professionals is dedicated to developing breakthrough treatments for asthma, organ transplant viability, and fibrosis.

Select one of the boxes below to learn more about our first product offering, its market opportunity, milestones and development plan.

Who We Are